To help make this website function we have placed cookies on your computer. You can see what cookies we have set at any time.
We'll assume that you're OK to continue using this site.

Don't show me this message again


Strides to divest Australian business Arrow

31 January 2019 • by Deborah Wilkes

Strides Pharma Science is selling its Australian business Arrow Pharmaceuticals to the Arrow-Apotex merged entity in a deal worth AUD394 million (USD285 million).

Conference Sponsors
  • CIG
  • Fine Foods
  • Orbital Research
  • SIIT
  • Precision